Dual Antiplatelet Therapy to Inhibit Coronary Atherosclerosis and Myocardial Injury in Patients With Necrotic High-Risk Coronary Plaque Disease
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 05 May 2017
At a glance
- Drugs Ticagrelor (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms DIAMOND
- 07 Jun 2017 Biomarkers information updated
- 02 May 2017 Planned End Date changed from 1 Jan 2018 to 1 May 2018.
- 02 May 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Jun 2017.